Company profile for Precision NanoSystems

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

The NanoAssemblr platform enables research of the genetic basis of disease and scaling of nanoparticle drug formulations. Precision NanoSystems Inc. (PNI) creates innovative solutions that empower researchers to harness powerful nanotechnology to transform our understanding and treatment of diseases. PNI’s NanoAssemblr™ Transfection Reagents use nanomedicine technology to deliver genetic materials in primary cells in vitr...
The NanoAssemblr platform enables research of the genetic basis of disease and scaling of nanoparticle drug formulations. Precision NanoSystems Inc. (PNI) creates innovative solutions that empower researchers to harness powerful nanotechnology to transform our understanding and treatment of diseases. PNI’s NanoAssemblr™ Transfection Reagents use nanomedicine technology to deliver genetic materials in primary cells in vitro and in vivo, enabling disease researchers to easily study gene function in high-value models of disease.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
#50 655 W Kent Ave N, Vancouver, BC V6P 6T7
Telephone
Telephone
+1 888-618-0031
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/precision-nanosystems-and-replicate-bioscience-in-licensing-deal-to-scale-up-genomic-medicines-301592835.html

PRNEWSWIRE
26 Jul 2022

https://www.contractpharma.com/contents/view_breaking-news/2021-08-11/precision-nanosystems-announces-plans-to-expand-global-headquarters/?widget=listSection

CONTRACT PHARMA
11 Aug 2021

https://www.prnewswire.com/news-releases/precision-nanosystems-announces-new-cell-therapy-reagent-for-lipid-nanoparticle--based-mrna-delivery-to-t-cells-301272197.html

PRNEWSWIRE
20 Apr 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty